Olgu Sunumu
BibTex RIS Kaynak Göster

Yıl 2019, Cilt: 6 Sayı: 8, 150 - 159, 30.08.2019

Tugce Uzar Gozde Duyu Ahmet Dirican Selda Gunaydin Nazli Topbasi Hulya Bayiz Şevket Özkaya

https://doi.org/10.17546/msd.564613

Öz

Kaynakça

  • 1. Aouadi S, Melki B, Braham E, et al. Eosinophilic lung disease. Eur Respir J 2016; 48.
  • 2. Jeong YJ, Kim K, Seo IJ, et al. Eosinophilic Lung Diseases: A Clinical, Radiologic, and Pathologic Overview. RadioGraphics 2007; 27:617– 639.
  • 3. Bernheim A, McLoud T. A Review of Clnical and Imaging Findings in Eosinophilic Lung Diseases. Am J of Roentgen. 2017;208: 1002-1010.
  • 4. Marchand E, Etienne-Mastroianni B, Chanez P, et al. Idiopathic chronic eosinophilic pneumonia and asthma: how do they influence each other? Eur Respir J 2003; 22:8.
  • 5. Allen JN, Davis WB. Eosinophilic lung diseases. Am J Respir Crit Care Med 1994;150:1423–1438.
  • 6. Johkoh T, Muller NL, Akira M, et al. Eosinophilic lung diseases: diagnostic accuracy of thin-section CT in 111 patients. Radiology 2000;216:773–780.
  • 7. Campos LE, Pereira LF. Pulmonary eosinophilia. J Bras Pneumol 35: 561-573, 2009.
  • 8. Solomon J, Schwarz M. Drug-, toxin-, and radiation therapy-induced eosinophilic pneumonia. Semin Respir Crit Care Med 27(2): 192-197, 2006.
  • 9. Rizos E, Tsigkaropoulou E, Lambrou P. Risperidone-induced Acute Eosinophilic Pneumonia. In Vivo 2013;27 (5): 651-653.
  • 10. Mann B. Eosinophilic lung disease. Clinical medicine. Circulatory, respiratory and pulmonary medicine. 2008 Jan;2:CCRPM-S575.

Evaluation and treatment of the eosinophilic lung diseases in 7 patients

Yıl 2019, Cilt: 6 Sayı: 8, 150 - 159, 30.08.2019

Tugce Uzar Gozde Duyu Ahmet Dirican Selda Gunaydin Nazli Topbasi Hulya Bayiz Şevket Özkaya

https://doi.org/10.17546/msd.564613

Öz





Objective:
Eosinophilic lung diseases (ELD) are a rare group of heterogeneous
diseases characterized by the increase of the eosinophilic ratio in the airways
and lung parenchyma. We aimed to present and discuss the clinical, radiologic
and pathologic features of six patients with eosinophilic lung diseases.


Conclusion:
Peripheral eosinophilia with pulmonary infiltrates is diagnostic
clues of eosinophilic lung diseases. Systemic corticosteroids are provided
rapid control not only in symptoms but also radiological and clinical
improvement of ELD.

Anahtar Kelimeler

eosinophilic lung diseases acute eosinophilic pneumonia chronic eosinophilic pneumonia Case

Kaynakça

  • 1. Aouadi S, Melki B, Braham E, et al. Eosinophilic lung disease. Eur Respir J 2016; 48.
  • 2. Jeong YJ, Kim K, Seo IJ, et al. Eosinophilic Lung Diseases: A Clinical, Radiologic, and Pathologic Overview. RadioGraphics 2007; 27:617– 639.
  • 3. Bernheim A, McLoud T. A Review of Clnical and Imaging Findings in Eosinophilic Lung Diseases. Am J of Roentgen. 2017;208: 1002-1010.
  • 4. Marchand E, Etienne-Mastroianni B, Chanez P, et al. Idiopathic chronic eosinophilic pneumonia and asthma: how do they influence each other? Eur Respir J 2003; 22:8.
  • 5. Allen JN, Davis WB. Eosinophilic lung diseases. Am J Respir Crit Care Med 1994;150:1423–1438.
  • 6. Johkoh T, Muller NL, Akira M, et al. Eosinophilic lung diseases: diagnostic accuracy of thin-section CT in 111 patients. Radiology 2000;216:773–780.
  • 7. Campos LE, Pereira LF. Pulmonary eosinophilia. J Bras Pneumol 35: 561-573, 2009.
  • 8. Solomon J, Schwarz M. Drug-, toxin-, and radiation therapy-induced eosinophilic pneumonia. Semin Respir Crit Care Med 27(2): 192-197, 2006.
  • 9. Rizos E, Tsigkaropoulou E, Lambrou P. Risperidone-induced Acute Eosinophilic Pneumonia. In Vivo 2013;27 (5): 651-653.
  • 10. Mann B. Eosinophilic lung disease. Clinical medicine. Circulatory, respiratory and pulmonary medicine. 2008 Jan;2:CCRPM-S575.
Toplam 10 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Sağlık Kurumları Yönetimi
Bölüm Vaka Sunumu
Yazarlar

Tugce Uzar Bu kişi benim

Gozde Duyu Bu kişi benim

Ahmet Dirican Bu kişi benim

Selda Gunaydin Bu kişi benim

Nazli Topbasi Bu kişi benim

Hulya Bayiz Bu kişi benim

Şevket Özkaya

Yayımlanma Tarihi 30 Ağustos 2019
Yayımlandığı Sayı Yıl 2019 Cilt: 6 Sayı: 8

Kaynak Göster

APA Uzar, T., Duyu, G., Dirican, A., … Gunaydin, S. (2019). Evaluation and treatment of the eosinophilic lung diseases in 7 patients. Medical Science and Discovery, 6(8), 150-159. https://doi.org/10.17546/msd.564613
AMA Uzar T, Duyu G, Dirican A, vd. Evaluation and treatment of the eosinophilic lung diseases in 7 patients. Med Sci Discov. Ağustos 2019;6(8):150-159. doi:10.17546/msd.564613
Chicago Uzar, Tugce, Gozde Duyu, Ahmet Dirican, Selda Gunaydin, Nazli Topbasi, Hulya Bayiz, ve Şevket Özkaya. “Evaluation and treatment of the eosinophilic lung diseases in 7 patients”. Medical Science and Discovery 6, sy. 8 (Ağustos 2019): 150-59. https://doi.org/10.17546/msd.564613.
EndNote Uzar T, Duyu G, Dirican A, Gunaydin S, Topbasi N, Bayiz H, Özkaya Ş (01 Ağustos 2019) Evaluation and treatment of the eosinophilic lung diseases in 7 patients. Medical Science and Discovery 6 8 150–159.
IEEE T. Uzar, G. Duyu, A. Dirican, S. Gunaydin, N. Topbasi, H. Bayiz, ve Ş. Özkaya, “Evaluation and treatment of the eosinophilic lung diseases in 7 patients”, Med Sci Discov, c. 6, sy. 8, ss. 150–159, 2019, doi: 10.17546/msd.564613.
ISNAD Uzar, Tugce vd. “Evaluation and treatment of the eosinophilic lung diseases in 7 patients”. Medical Science and Discovery 6/8 (Ağustos2019), 150-159. https://doi.org/10.17546/msd.564613.
JAMA Uzar T, Duyu G, Dirican A, Gunaydin S, Topbasi N, Bayiz H, Özkaya Ş. Evaluation and treatment of the eosinophilic lung diseases in 7 patients. Med Sci Discov. 2019;6:150–159.
MLA Uzar, Tugce vd. “Evaluation and treatment of the eosinophilic lung diseases in 7 patients”. Medical Science and Discovery, c. 6, sy. 8, 2019, ss. 150-9, doi:10.17546/msd.564613.
Vancouver Uzar T, Duyu G, Dirican A, Gunaydin S, Topbasi N, Bayiz H, vd. Evaluation and treatment of the eosinophilic lung diseases in 7 patients. Med Sci Discov. 2019;6(8):150-9.
 Kapak Resmi İndir